Potential Synergy of Epigenetic Modifiers with Tyrosine Kinase
Inhibitors in FLT3-ITD AMLÂ
Aditi Dhir, M.D.
Fellow, Division of Hematology/Oncology
Oncolytic Herpes Virus for the Treatment of Pediatric Brain Tumors
Charles Schlappi, M.D.
Fellow, Division of Hematology/Oncology
Friday, June 21, 2019 at 12:00pm to 1:00pm
Children's Hospital Harbor Center, Bradley Lecture Center
1600 6th Avenue South, Birmingham, AL 35233
No recent activity